Nanotech could revolutionise global healthcare

 

Impact likely to be most profound in developing world.

Nanotechnology has the potential to generate "enormous" health benefits for the more than five billion people living in the developing world, according to a leading professor of medicine.

However, Dr Peter Singer, senior scientist at the McLaughlin-Rotman Centre for Global Health, and professor of medicine at University of Toronto, warned that it remains to be seen whether novel applications of nanotechnology will deliver on their promise.

"A fundamental problem is that people are not engaged and are not talking to each other," he said. "And business has little incentive to invest in the appropriate nanotechnology research targeted at the developing world."

Dr Singer explained that this is shown by the lack of new drugs for malaria, dengue fever and other diseases that disproportionately affect people in developing countries.

The professor's group in Toronto published a study in 2005 identifying and ranking the 10 nanotechnologies most likely to benefit the developing world in the near future.

Applications related to energy storage, production and conversion, agricultural productivity enhancement, water treatment and remediation, and diagnosis and treatment of diseases topped the list.

Dr Andrew Maynard, chief science advisor for the Project on Emerging Nanotechnologies, said: "Countries like Brazil, India, China and South Africa have significant nanotechnology research initiatives that could be directed towards the particular needs of the poor.

"But if market forces are the only dynamic there is still a danger that small minorities in wealthy nations will benefit from nanotechnology breakthroughs in the health sector, while large majorities, mainly in the developing world, will not."

Dr Piotr Grodzinski, director of the National Cancer Institute's Alliance for Nanotechnology in Cancer, added: "It is my belief that nano-materials and nano-medical devices will play increasingly critical and beneficial roles in improving the way we diagnose, treat and ultimately prevent cancer and other diseases.

"But we face challenges because the complexity of clinical implementation and the treatment cost may cause the gradual, rather than immediate, distribution of these novel yet effective approaches."

Dr Maynard cited one example of a future application in which citizens in the developing world could place contaminated water in inexpensive transparent bottles that would cause the water to be disinfected when placed in direct sunlight.

Copyright ©v3.co.uk


Nanotech could revolutionise global healthcare
 
 
 
Top Stories
Matching databases to Linux distros
Reviewed: OS-repository DBMSs, MariaDB vs MySQL.
 
Coalition's NBN cost-benefit study finds in favour of MTM
FTTP costs too much, would take too long.
 
Who'd have picked a BlackBerry for the Internet of Things?
[Blog] BlackBerry has a more secure future in the physical world.
 
 
Sign up to receive iTnews email bulletins
   FOLLOW US...
Latest Comments
Polls
Which is the most prevalent cyber attack method your organisation faces?




   |   View results
Phishing and social engineering
  71%
 
Advanced persistent threats
  3%
 
Unpatched or unsupported software vulnerabilities
  11%
 
Denial of service attacks
  6%
 
Insider threats
  10%
TOTAL VOTES: 762

Vote